Cure ETF
CURE:ASX has switched to Algo Engine buy conditions.
CURE:ASX has switched to Algo Engine buy conditions.
Crypto business Ripple has flagged plans to launch a stablecoin that will be 100 per cent backed by US dollar deposits, short-term US government treasuries, and other cash equivalents.
Ripple said a third-party accounting firm will audit its reserves to make sure they reconcile
ALL:ASX shares will likely find increased buying activity within the $40 – $41.50 price range.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
NAB:ASX is added to the “short list” with a stop loss at $34.92
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
RMS:ASX is up 38% after a 33-day holding period.
Or start a free thirty day trial for our full service, which includes our ASX Research.